BLUE
Price:
$4.97
Market Cap:
$48.67M
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment...[Read more]
Industry
Biotechnology
IPO Date
2013-06-19
Stock Exchange
NASDAQ
Ticker
BLUE
According to bluebird bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 158.07M. This represents a change of -81.65% compared to the average of 861.30M of the last 4 quarters.
The mean historical Enterprise Value of bluebird bio, Inc. over the last ten years is 34.92B. The current 158.07M Enterprise Value has changed -54.73% with respect to the historical average. Over the past ten years (40 quarters), BLUE's Enterprise Value was at its highest in in the March 2019 quarter at 112.51B. The Enterprise Value was at its lowest in in the March 2025 quarter at 156.98M.
Average
34.92B
Median
29.17B
Minimum
376.74M
Maximum
99.78B
Discovering the peaks and valleys of bluebird bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 236.82%
Maximum Annual Enterprise Value = 99.78B
Minimum Annual Increase = -81.87%
Minimum Annual Enterprise Value = 376.74M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 376.74M | -81.87% |
| 2023 | 2.08B | -81.33% |
| 2022 | 11.13B | -18.74% |
| 2021 | 13.70B | -60.46% |
| 2020 | 34.64B | -44.64% |
| 2019 | 62.57B | -6.03% |
| 2018 | 66.58B | -33.28% |
| 2017 | 99.78B | 236.82% |
| 2016 | 29.62B | 3.14% |
| 2015 | 28.72B | -7.87% |
The current Enterprise Value of bluebird bio, Inc. (BLUE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.53B
5-year avg
12.38B
10-year avg
34.92B
bluebird bio, Inc.’s Enterprise Value is less than Spyre Therapeutics, Inc. (1.97B), greater than GreenLight Biosciences Holdings (57.81M), greater than Lunai Bioworks Inc. (35.00M), greater than AlloVir, Inc. (68.85M), greater than Rein Therapeutics Inc. (31.96M), greater than Magenta Therapeutics, Inc. (-12257976.00), greater than ERYTECH Pharma S.A. (3.80M), greater than Kronos Bio, Inc. (-13835104.00), greater than TCR2 Therapeutics Inc. (79.12M), greater than Pluristem Therapeutics Inc. (43.29M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.97B | $2.04B | |
| 57.81M | $45.43M | |
| 35.00M | $32.92M | |
| 68.85M | $49.48M | |
| 31.96M | $36.01M | |
| -12257976.00 | $42.44M | |
| 3.80M | $47.38M | |
| -13835104.00 | $53.65M | |
| 79.12M | $58.11M | |
| 43.29M | $40.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bluebird bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like bluebird bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is bluebird bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for bluebird bio, Inc. (BLUE)?
What is the 3-year average Enterprise Value for bluebird bio, Inc. (BLUE)?
What is the 5-year average Enterprise Value for bluebird bio, Inc. (BLUE)?
How does the current Enterprise Value for bluebird bio, Inc. (BLUE) compare to its historical average?